Search all trials

Find therapies in clinical trials near you – page 45

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Endometrial cancer

Not recruiting

Registered drug

Study of Navtemadlin as Maintenance Therapy for Patients with Advanced or Recurrent Endometrial Cancer After Chemotherapy

Registered drug

Italy

Participants:18–64 years · 65+ years
Substances:Loperamide

Contact Research Centre

B-cell type acute leukaemia

Not recruiting

Registered drugNo placebo

Study of UCART22 for Patients with Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia

Registered drugNo placebo

Italy

Participants:0–17 years · 18–64 years
Substances:Alemtuzumab

Contact Research Centre

Early onset familial Alzheimer's disease

Not recruiting

Investigational

Study on the Safety and Effects of ABBV-916 and MK-6240 for Patients with Early Alzheimer's Disease

Investigational

Italy

Participants:18–64 years · 65+ years
Substances:Florquinitau (18F)

Contact Research Centre

Endometrial cancer

Not recruiting

Registered drug

Study of Pembrolizumab with Chemotherapy for High-Risk Endometrial Cancer Patients After Surgery

Registered drug

Italy

Participants:18–64 years · 65+ years
Substances:Anhydrous Docetaxel

Contact Research Centre

Ovarian cancer recurrent

Not recruiting

Registered drug

Study of Pembrolizumab, Paclitaxel, and Bevacizumab for Patients with Platinum-Resistant Recurrent Ovarian Cancer

Registered drug

Italy

Participants:18–64 years · 65+ years
Substances:Anhydrous Docetaxel

Contact Research Centre

Dementia Alzheimer's type

Not recruiting

Registered drug

Study on the Safety and Effects of BIIB080 for Patients Aged 50-80 with Mild Cognitive Impairment or Mild Alzheimer's Disease Dementia

Registered drug

Italy

Participants:18–64 years · 65+ years
Substances:Florbetaben (18F)

Contact Research Centre

Dermatitis atopic

Not recruiting

Registered drugNo placebo

Study on the Long-Term Safety and Effectiveness of Amlitelimab for Adults with Moderate to Severe Atopic Dermatitis

Registered drugNo placebo

Italy

Participants:0–17 years · 18–64 years · 65+ years
Substances:Amlitelimab

Contact Research Centre

Magnetic resonance imaging+1

Not recruiting

Registered drugNo placebo

Study Comparing Gadoquatrane with Gadoteric Acid, Gadoteridol, and Gadobutrol for MRI in Patients with Non-CNS Conditions

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Gadobutrol

Contact Research Centre

Hodgkin's disease

Not recruiting

Registered drugNo placebo

Study of Pembrolizumab and Chemotherapy for Patients with Newly Diagnosed Classical Hodgkin Lymphoma

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Bleomycin

Contact Research Centre

Diffuse large B-cell lymphoma

Not recruiting

Registered drugNo placebo

Study Comparing Axicabtagene Ciloleucel and Standard Treatment for Adults with High-Risk Large B-Cell Lymphoma

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Cyclophosphamide

Contact Research Centre

Systemic lupus erythematosus

Not recruiting

Registered drugNo placebo

Study on the Effects and Safety of Belimumab for Adults with Early Systemic Lupus Erythematosus

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Belimumab

Contact Research Centre

Study on Langerhans Cell Histiocytosis Treatment in Children and Adolescents Using Cladribine, Prednisolone, and Cytarabine

Not recruiting

Registered drugNo placebo

Study on Langerhans Cell Histiocytosis Treatment in Children and Adolescents Using Cladribine, Prednisolone, and Cytarabine

Registered drugNo placebo

Italy

Participants:0–17 years
Substances:Alemtuzumab

Contact Research Centre

Find therapies in clinical trials near you – page 45

554 trials match your criteria

Endometrial cancer

Study of Navtemadlin as Maintenance Therapy for Patients with Advanced or Recurrent Endometrial Cancer After Chemotherapy

B-cell type acute leukaemia

Study of UCART22 for Patients with Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia

Early onset familial Alzheimer's disease

Study on the Safety and Effects of ABBV-916 and MK-6240 for Patients with Early Alzheimer's Disease

Endometrial cancer

Study of Pembrolizumab with Chemotherapy for High-Risk Endometrial Cancer Patients After Surgery

Ovarian cancer recurrent

Study of Pembrolizumab, Paclitaxel, and Bevacizumab for Patients with Platinum-Resistant Recurrent Ovarian Cancer

Dementia Alzheimer's type

Study on the Safety and Effects of BIIB080 for Patients Aged 50-80 with Mild Cognitive Impairment or Mild Alzheimer's Disease Dementia

Dermatitis atopic

Study on the Long-Term Safety and Effectiveness of Amlitelimab for Adults with Moderate to Severe Atopic Dermatitis

Magnetic resonance imaging+1

Study Comparing Gadoquatrane with Gadoteric Acid, Gadoteridol, and Gadobutrol for MRI in Patients with Non-CNS Conditions

Hodgkin's disease

Study of Pembrolizumab and Chemotherapy for Patients with Newly Diagnosed Classical Hodgkin Lymphoma

Diffuse large B-cell lymphoma

Study Comparing Axicabtagene Ciloleucel and Standard Treatment for Adults with High-Risk Large B-Cell Lymphoma

Systemic lupus erythematosus

Study on the Effects and Safety of Belimumab for Adults with Early Systemic Lupus Erythematosus

Study on Langerhans Cell Histiocytosis Treatment in Children and Adolescents Using Cladribine, Prednisolone, and Cytarabine

Study on Langerhans Cell Histiocytosis Treatment in Children and Adolescents Using Cladribine, Prednisolone, and Cytarabine

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.